DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Pfizer (NYSE: PFE)



company name or ticker
Company Photos
(Click to zoom)

United Therapeutics Lung Drug Keeps Going And Going

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

Update: AstraZeneca Wins EU Approval For Lynparza

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog

Tax Inversions Wrap Up

Pfizer Is A Great Income Stock On A Pullback

Jacobs Drives Organic Growth on Award-Winning Contract - Analyst Blog

OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog

Why The Smart Money is Betting Billions On PetSmart

In one of the biggest leveraged buyouts of the year, the pet supplier strains at the leash of valuation
See More Articles...